000 01187 a2200337 4500
005 20250513054743.0
264 0 _c19940802
008 199408s 0 0 eng d
022 _a0114-5916
024 7 _a10.2165/00002018-199410040-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrover, S A
245 0 0 _aRisk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modification.
_h[electronic resource]
260 _bDrug safety
_cApr 1994
300 _a301-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdult
650 0 4 _aComputer Simulation
650 0 4 _aCoronary Disease
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aLife Expectancy
650 0 4 _aMale
650 0 4 _aModels, Cardiovascular
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRisk Factors
700 1 _aCoupal, L
773 0 _tDrug safety
_gvol. 10
_gno. 4
_gp. 301-9
856 4 0 _uhttps://doi.org/10.2165/00002018-199410040-00004
_zAvailable from publisher's website
999 _c8017630
_d8017630